Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
A UK study has uncovered a genetic basis that explains why certain lung cancers are more likely to spread.
The research was published in the journal Nature and focused on lung cancers where a particular gene, called the Kras gene, changes and makes copies of itself, leading to the growth of a tumour. This happens in about 30% of adenocarcinomas, the most common form of lung cancer.
Scientists studied tumours with this faulty Kras gene in mice. They found that tumour cells with multiple copies of the altered Kras gene were able to absorb more energy from the body. The cells were therefore more able to survive and spread throughout the body.
This process is described by the researchers as a ‘rewiring’ of the cells’ energy supply.The scientists believe that this finding could hold promise for people with this type of lung cancer, as cancers with this faulty Kras gene can be resistant to current treatments. Further research into how to target the gene and stop or prevent this behaviour is now needed.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79